The Delta variant of the SARS-CoV-2 virus is expected to become the dominant strain in the United States within weeks. This variant is 50 to 90 percent more infectious, and it appears to be more likely to cause hospitalizations. With only 30 percent of Alabama’s population fully vaccinated, some healthcare providers are concerned COVID-19 may resurge this fall. DOM infectious diseases experts emphasize that the mRNA vaccines are up to 90 percent effective against variants of the virus and the best way to avoid infection and serious illness is to get fully vaccinated.
More Good News for July 9, 2021
As part of our Faculty Honors recognition series, the Department is delighted to announce the 2021 C. Glenn Cobbs/Edwin A. Rutsky Award for Clinical Excellence . These awards were established to honor physicians whose service extends Drs. Cobbs' and Rutsky's legacy of delivering extraordinary care to our patients.
William M. Geisler, M.D., MPH (Professor, Infectious Diseases) has been named the assistant dean for Physician Scientist Development in UAB School of Medicine. His office will help trainees develop research portfolios, establish mentoring teams, obtain grant funding, and develop their careers. His appointment was effective June 1.
Nephrologists Christian Faul, Ph.D. (Associate Professor) and Orlando Gutiérrez, M.D., MMSc (Professor) are editors of a new textbook on Fibroblast Growth Factor 23 (FGF23), the first to focus exclusively on the signaling protein. Chapters explore the diversity of FGF23's actions and its role as a regulator of phosphate metabolism.
Navin Nanda, M.D., (Professor, Cardiovascular Disease) will serve as the International President for the World Congress of Echocardiography and Allied Techniques in October. The conference will update physicians on recent advances in cardiac and peripheral imaging and relevant COVID-19 complications.
Professor Isabel Scarinci, Ph.D., MPH, has been named Vice Chair for Global and Rural Health in the Department of Obstetrics and Gynecology. This new role will capitalize on her 19 years of research in women's health and cancer prevention in the Division of Preventive Medicine. Good luck in this new role, Dr. Scarinci!
The DOM is delighted to welcome Sravanti Rangaraju, M.D. (Assistant Professor, Hematology and Oncology). She joins us from Indiana University, where she was a Chief Fellow. Dr. Rangaraju’s clinical practice focuses on the care of patients with acute lymphoid and myeloid leukemias. Welcome to the UAB family Dr. Rangaraju!